IDENTIFICATION OF HUB BIOMARKERS AND THERAPEUTIC AGENTS FOR RENAL INTERSTITIAL FIBROSIS THROUGH BIOINFORMATICS ANALYSIS AND EXPERIMENTAL VALIDATION